Prosecution Insights
Last updated: April 19, 2026

Examiner: AMIN, ALPA NILESH

Tech Center 1600 • Art Units: 1655

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
17
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

12.3%
§101 Eligibility
12.3%
§102 Novelty
40.4%
§103 Obviousness
31.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18650858 METHOD TO INHIBIT FUNCTION OF 5-ALPHA REDUCTASE IN THE SCALP SKIN THROUGH COMBINATION OF PLANT-DERIVED EXTRACTS IN A COSMETIC COMPOSITION Non-Final OA KILGOURMD, INC
18645866 SPIDER WEB ERADICATION AND SPIDER REPELLANT COMPOUND AND METHODS OF USE Non-Final OA DALRAY, LLC.
18639308 OVER-THE-COUNTER TRADITIONAL CHINESE MEDICINE FOR WEIGHT LOSS Non-Final OA Chongqing Kangershou Biopharmaceutical Technology Co., Ltd
18620027 Rinse-Free Nutrient Rich Rinse Non-Final OA AIH PERSONAL CARE PRO, LLC
18012321 SALVIA PLEBIA AND SCUTELLARIAE RADIX COMPOUND ACNE CREAM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Non-Final OA SOOCHOW UNIVERSITY
18580340 SINGLE PROCESS FOR SEQUENTIAL EXTRACTION OF PRODUCTS FROM GREEN TEA LEAVES Non-Final OA Council of Scientific and Industrial Research
18444601 METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS Non-Final OA Aviratek Biomedical Solutions LLC
18682066 PEDICULICIDAL COMPOSITION Non-Final OA OYSTERSHELL NV
18544023 CONCOMITANT ADMINISTRATION OF OILS FOR MANAGING NEURODEGENERATIVE DISEASES AND DEVELOPMENTAL DISORDERS Non-Final OA UNIVERSIDAD DE CUENCA
18566993 USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS Non-Final OA Chang Gung University of Science and Technology
18565976 INSECTICIDAL COMPOSITION FOR AGRICULTURAL OR HORTICULTURAL USE AND METHOD OF CONTROLLING AGRICULTURAL OR HORTICULTURAL PEST Non-Final OA SDS BIOTECH K.K
18006463 METHOD FOR PRODUCING A PURIFIED CANNABINOID EXTRACT, AND A PURIFIED CANNABINOID EXTRACT OBTAINED THEREFROM Non-Final OA PURCANN PHARMA INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month